A Phase 3, Multicenter, Randomized, Double-Blind, Parallel-Arm, Placebo-Controlled Maintenance Study of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 2)
收藏DataCite Commons2026-04-27 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00010142/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to evaluate the efficacy and safety of mirikizumab as
maintenance therapy in participants who completed as clinical responders in the prior 12-week
induction study LUCENT-1 (NCT03518086).
提供机构：
Vivli
创建时间：
2024-05-29
